Prospective Long-Term Outcomes of a Standardized Ross Procedure
Part of paid clinical trials in Plano, Texas.
- Sponsor
- Baylor Research Institute
- Study ID
- NCT06352671
- Status
- Recruiting
Conditions
- Aortic Valve Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.
Key Dates
- Start date
- Oct 12, 2023
- Status verified
- Feb 2026
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 225 participants (estimated)
Primary Outcome Measure
Survival of the patient [ Time Frame: 1 year, 5 year and 10 year ]
Central Contacts
- Bonnie Ostergren4698144181
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baylor Scott and White Heart Hospital | Plano | Texas | 75093 | William Brinkman, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Plano, TX
By research site
Related Studies
- ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve ImplantationEnrolling By Invitation · Abbott Medical Devices · Birmingham, Alabama
- The JenaValve ALIGN-AR LVAD RegistryRecruiting · JenaValve Technology, Inc. · Los Angeles, California
- Valved Graft PMCF StudyRecruiting · Abbott Medical Devices · Birmingham, Alabama
- Quantification of Debris Captured Using TCEP During VIV TAVR With BVFRecruiting · Saint Luke's Health System · Kansas City, Missouri